In 1994, Edward M. Connor and colleagues published “Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment.” Their study summarized how to reduce the transfer of human immunodeficiency virus, or HIV, from pregnant women to their fetuses with Zidovudine, otherwise known as AZT. HIV is a virus that weakens the immune system by destroying white blood cells, a part of the body’s immune system. Fifteen to forty percent of infants born to HIV-positive mothers become infected during fetal development, labor and delivery, or breast-feeding. From April 1991 to December 1993, Connor and his colleagues researched HIV-positive pregnant women who took AZT, a drug that treats but does not cure an HIV infection. In their article, Conner and colleagues showed that AZT decreased the maternal-infant transmission of HIV and helped decrease infant mortality due to the viral infection.

Luc Montagnier studied viruses, the immune system, and cancer in France during the second half of the twentieth century. In his early career, Montagnier studied how cancer-causing viruses replicate and infect host cells. He received the Nobel Prize in Physiology or Medicine in 2008 for his team’s discovery that a retrovirus, human immunodeficiency virus, or HIV, was the cause of acquired immunodeficiency syndrome, or AIDS. AIDS is a chronic condition that results from HIV infection and damages the immune system. People who have AIDS typically experience increased vulnerability to a variety of diseases. Before Montagnier’s research on the virus, the exact cause of AIDS remained unknown to researchers and healthcare professionals. Beyond discovering HIV as the cause of AIDS, Montagnier’s work advanced a general understanding of how viral infection affects the immune system of the host organism.